Navigation Links
Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection

and neutropenia. There have been reports of gastrointestinal and intracerebral hemorrhage in association with VELCADE. Transfusions may be considered. Complete blood counts (CBC) should be frequently monitored during treatment with VELCADE. Rare cases of acute liver failure have been reported in patients receiving multiple concomitant medications and with serious underlying medical conditions.

Safety Data: In 1163 patients in multiple myeloma and mantle cell lymphoma studies, the most commonly reported adverse events were asthenic conditions (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy (39%), thrombocytopenia (36%), appetite decrease, including reports of anorexia (36%), pyrexia (34%), vomiting (33%) and anemia (29%). Twenty percent of patients reported at least one episode of grade 4 toxicity; the most common grade 4 toxicities were thrombocytopenia (5%) and neutropenia (3%). Fifty percent of patients reported serious adverse events. The most commonly reported serious adverse events were pneumonia (7%), pyrexia (6%), diarrhea (5%), vomiting (4%), and nausea, dehydration, dyspnea and thrombocytopenia (each 3%).

For more information about VELCADE clinical trials, patients and physicians can contact the Millennium Medical Product Information Department at 1-866-VELCADE (1-866-835-2233).

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical development pipeline of product candidates. Millennium's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of nine innovative product candidates. Millennium's website is




Page: 1 2 3 4 5 6

Related medicine technology :

1. Research Supported by Samuel Waxman Cancer Research Foundation Discovers Mode of Action of Arsenic-Based Drugs in Destroying Cancer Cells
2. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
3. Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
4. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
5. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
6. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
7. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
8. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
9. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
10. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
11. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
Post Your Comments:
(Date:7/29/2015)... July 29, 2015 At the 2015 ... will present findings that a first-of-its-kind smartphone test ... accuracy, which could reduce the prevalence of this ... easier and cheaper. Most people with ... infection often causes no symptoms, but if left ...
(Date:7/29/2015)... DUBLIN , July 27, 2015 ... the addition of the "Pharmaceutical Packaging Market by ... by Region(North America, Europe, Asia-Pacific, RoW) - Forecasts to ... global pharmaceutical packaging market demand, by value is estimated ... The pharmaceutical packaging market is anticipated to show a ...
(Date:7/29/2015)... RATON, Fla. , July 29, 2015 /PRNewswire/ ... launch of Azelastine HCl Nasal Solution, 0.1%. The U.S. ... Abbreviated New Drug Application (ANDA), which is AB ... Pharmaceuticals. Azelastine hydrochloride nasal solution (nasal spray) is ... June 2015 IMS Health sales data.  Azelastine HCl ...
Breaking Medicine Technology:First Smartphone DNA Test for Chlamydia to Be Presented at 2015 AACC Annual Meeting 2First Smartphone DNA Test for Chlamydia to Be Presented at 2015 AACC Annual Meeting 3Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 for the $80 Billion Industry 2Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 for the $80 Billion Industry 3
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... July is National UV Awareness Month, and ... Washington, DC shares tips on how to protect skin from the sun, as well as ... skin cancer, and is one of the most common skin conditions in America. Many people ...
(Date:7/29/2015)... ... , ... Employee Fiduciary, LLC announces the launch of its new, online Financial ... plans administered, years in business, and credentials of all Employee Fiduciary financial advisor ... Employee Fiduciary. A search can be done by zip code so a plan sponsor ...
(Date:7/29/2015)... MO (PRWEB) , ... July 29, 2015 , ... Attorneys ... the Talcum Powder Cancer Lawsuit Center. The website now features a page dedicated to ... news pieces from other sources. The Talcum Powder Lawsuit News page was ...
(Date:7/29/2015)... , ... July 29, 2015 , ... " mybody ” ... look at small, medium and large businesses making an impact in their industry. Andrew ... with viewers how these advanced probiotic skincare products are designed to strengthen the skin’s ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... People that ... from two new products on Mercola.com: a vertical “garden tower” and enhanced mineral product ... be squeezed into small corners on a porch, balcony, or rooftop – can hold ...
Breaking Medicine News(10 mins):Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2
... 10, 2008 IPC,The Hospitalist Company, Inc. (Nasdaq: ... the delivery of hospitalist medicine services,announced today that it ... 31, 2008 on Wednesday, May 14, 2008, after the ... results will begin at 5:00 p.m. ET,(2:00 p.m. PT) ...
... available for comment, PHILADELPHIA, April 10 The ... letter on,Thursday, calling on the major Democratic candidates campaigning ... healthcare access and,lower costs in SB 1137, HB 2098 ... 10, 2008, Dear Senator Clinton and Senator Obama:, ...
... Why are you so disappointed?, CHICAGO, April 10 ... It has to do with changing expectations., Businesses ... an attitude,that says, "We need a web presence. Now!" We ... the web!, This realization is usually followed by weeks ...
... Meets Number One Consumer Request, PLANO, Texas, April ... the launch of Pinch of Salt, a,low-sodium version of ... Tostitos tortilla chips, Fritos corn chips and Ruffles potato ... to begin with,-- for instance Lay,s Classic potato chips ...
... BENSALEM, Pa., April 9 Law Offices of ... against Merck & Co., Inc.,("Merck" or the "Company")(NYSE: ... and Security Plan (the "Plan") imprudently invested in,Merck ... fiduciary,duties to the Plan,s participants in violation of ...
... ANGELES, April 9 The Los Angeles ... children hospitalized for,cancer and other serious illnesses, ... a half block from its original Fountain ... low cost, often free, lodging to,75-families per ...
Cached Medicine News:Health News:IPC The Hospitalist Company, Inc. to Report First Quarter 2008 Financial Results 2Health News:Open Letter to Presidential Candidates on State Health Care Reform 2Health News:So ... You Went and Got a Pretty Web Site. 2Health News:Frito-Lay Launches Low Sodium Versions of its Top Selling Snack Chips 2Health News:Los Angeles Ronald McDonald House Doubles Lodging Capacity for Families of Hospitalized Children 2Health News:Los Angeles Ronald McDonald House Doubles Lodging Capacity for Families of Hospitalized Children 3
... Used for stone manipulation and removal in ... the basket to retain its shape following extreme ... stone capture by allowing the basket to open ... the stone. The tipless design reduces the likelihood ...
... Used for soft-tissue ... limited to paravaginal repairs, ... or rectocele. Surgisis® ES ... enhanced strength for intraoperative ...
... for temporary suprapubic urinary diversion and drainage. ... bladder. The access sheath is left in ... catheter is introduced, the access sheath is ... support is included for external catheter retention. ...
... B19 ASR contains primers and a FAM-labeled probe ... addition, the Parvo B19 ASR contains primers and ... sequence. This ASR requires an instrument that can ... SmartCycler System., The Cepheid Analyte Specific Reagent* (ASR) ...
Medicine Products: